Lumos Pharma Inc (LUMO)
4.33
+0.01
(+0.23%)
USD |
NASDAQ |
Nov 21, 16:00
4.33
0.00 (0.00%)
After-Hours: 20:00
Lumos Pharma Market Cap: 37.45M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 37.45M |
| November 20, 2024 | 37.36M |
| November 19, 2024 | 37.45M |
| November 18, 2024 | 37.36M |
| November 15, 2024 | 37.45M |
| November 14, 2024 | 37.45M |
| November 13, 2024 | 37.19M |
| November 12, 2024 | 37.71M |
| November 11, 2024 | 37.79M |
| November 08, 2024 | 37.70M |
| November 07, 2024 | 37.41M |
| November 06, 2024 | 37.28M |
| November 05, 2024 | 37.97M |
| November 04, 2024 | 38.18M |
| November 01, 2024 | 37.79M |
| October 31, 2024 | 38.40M |
| October 30, 2024 | 37.53M |
| October 29, 2024 | 37.79M |
| October 28, 2024 | 38.48M |
| October 25, 2024 | 38.05M |
| October 24, 2024 | 37.62M |
| October 23, 2024 | 37.71M |
| October 22, 2024 | 34.16M |
| October 21, 2024 | 32.26M |
| October 18, 2024 | 34.77M |
| Date | Value |
|---|---|
| October 17, 2024 | 32.69M |
| October 16, 2024 | 34.68M |
| October 15, 2024 | 34.51M |
| October 14, 2024 | 33.73M |
| October 11, 2024 | 32.78M |
| October 10, 2024 | 33.32M |
| October 09, 2024 | 32.17M |
| October 08, 2024 | 33.30M |
| October 07, 2024 | 33.38M |
| October 04, 2024 | 30.61M |
| October 03, 2024 | 31.57M |
| October 02, 2024 | 31.74M |
| October 01, 2024 | 31.05M |
| September 30, 2024 | 33.47M |
| September 27, 2024 | 32.01M |
| September 26, 2024 | 31.20M |
| September 25, 2024 | 32.90M |
| September 24, 2024 | 31.85M |
| September 23, 2024 | 30.55M |
| September 20, 2024 | 31.93M |
| September 19, 2024 | 31.85M |
| September 18, 2024 | 30.06M |
| September 17, 2024 | 31.52M |
| September 16, 2024 | 31.44M |
| September 13, 2024 | 31.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
11.78M
Minimum
Jul 18 2024
297.95M
Maximum
Dec 30 2020
65.15M
Average
63.59M
Median
Market Cap Benchmarks
| Boston Scientific Corp | 134.86B |
| Calidi Biotherapeutics Inc | 37.66M |
| NovaBay Pharmaceuticals Inc | 3.517M |
| Palatin Technologies Inc | 18.35M |
| iBio Inc | 22.42M |
Market Cap Related Metrics
| PS Ratio | 16.02 |
| PEG Ratio | -0.1392 |
| Price to Book Value | 7.621 |
| Price | 4.33 |
| Earnings Yield | -99.08% |
| PEGY Ratio | -0.1392 |